Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Scientists reveal antibiotic safe to treat babies with blood infection

15 February 2022

The-Star-logo

 

Scientists have revealed a new antibiotic that is safe to treat babies with a blood infection called neonatal sepsis.

Neonatal sepsis is a life-threatening blood infection that affects infants younger than three months, and requires prompt detection and treatment.

Clinical studies in Kenya show a dose of the antibiotic, Fosfomycin, is safe for babies with neonatal sepsis, which is usually caused by bacteria.

The NeoFosfo trial indicated that this is a significant development, as there are very few antibiotics specifically licensed to treat multidrug-resistant infections in babies.

The trial investigated the safety of Fosfomycin in 120 babies aged under 28 days who were hospitalised with clinically diagnosed sepsis at the Kilifi County hospital.

The trial was sponsored by the Global Antibiotic Research and Development Partnership and the Drugs for Neglected Diseases initiative.

 

Read the article